|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells显示文摘 | Goodman WA Levine AD Massari JV | 2009 | J Immunol2009，183，5： | 1 |
| 2 | Study of a kindred with pheochromocytnma, medunary thyroid carcinoma, hyperparathyroidism, and Cushing's disease:'mutiple endocrine neopIasia, type 2 显示文摘 | Steiner AL Goodman AD Powers SR | 1968 | Medicine (Baltimore)1968，47，5： | 1 |
| 3 | An openlabel safety and drug interaction study of natalizumab (Antegren)in combination with interferon-beta (Avonex) in patients with multiple sclerosis 显示文摘 | VOLLMER TL PHILLIPS JT GOODMAN AD | 2004 | Mult Scler2004，10，5： | 1 |
| 4 | IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells 显示文摘 | Goodman WA Levine AD Massari JV | 2009 | J Immunol2009，183，5： | 1 |
| 5 | An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis显示文摘 | Vollmer TL Phillips JT Goodman AD | 2004 | Mult Scler2004，10，5： | 1 |
| 6 | GLANCE:results of a phase 2,randomized,double-blind,placebo-controlled study显示文摘 | Goodman AD Rossman H Bar-Or A | 2009 | Neurology2009，72，9： | 1 |
| 7 | A phase 3 trial of extended release oral dalfampridine in multiple sclerosiss显示文摘 | Goodman AD Brown TR Edwards KR | 2010 | Ann Neurol2010，68，4： | 1 |
| 8 | Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer显示文摘 | Steg AD Katre AA Goodman B | | 0，，17： | 1 |
| 9 | Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer显示文摘 | Steg AD Katre AA Goodman B | 2011 | Clin Cancer Res2011，17，17： | 1 |
| 10 | Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer显示文摘 | Steq AD Katre AA Goodman B | 2011 | ClinCancerRes2011，17，17： | 1 |
| 11 | Safety and efficacy of risk-adapted eyelophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis显示文摘 | Wechalekar AD Goodman HJ LaehmannIII | 2007 | Blood2007，109，2： | 1 |
| 12 | Safety and efficacy of risk-adapted cyclophosphamide,thalidomide,and dexamethasone insystemic AL amyloidosis显示文摘 | Wechalekar AD Goodman HJ Lachmann HJ | 2007 | Blood2007，109，： | 1 |
| 13 | Receptors and growth-promoting effects of insulin and insulin like growth factors on cells from bovine retinal capillaries and aorta显示文摘 | Goodman AD Buzney S et sl | 1985 | J Clin Invest1985，85，： | 1 |
| 14 | Receptor and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta 显示文摘 | King GL Goodman AD Buzney S | 1985 | J Clin Invest1985，75，3： | 1 |
| 15 | Safety and efficacy of risk-adapted cyclophosphamide,thalidomide,and dexamethasone in systemic AL amyloidosis显示文摘 | Wechalekar AD Goodman HJB Lachmann HJ | 2007 | Blood2007，109，2： | 1 |
| 16 | Enhancing neural transmission m multiple sclerosis ( 4-aminopyridine therapy ) 显示文摘 | Goodman AD Stone RT | 2013 | Neurotherapeutics2013，10，： | 1 |
| 17 | IL 6 signaling in psoriasis prevents immune suppression by regulatory T cells显示文摘 | Goodman WA Levine AD Massari JV | 2009 | J Immunol2009，183，5： | 1 |
| 18 | Fampridine-SR in multiple sclerosis:a randomized,double-blind,placebo-controlled,dose-ranging study显示文摘 | Goodman AD Cohen JA Cross A | | 0，，03： | 1 |
| 19 | Does comparison trial of sustained-release fampridine in multiple sclerosis显示文摘 | Goodman AD Brown TR Cohen JA | | 0，，15： | 1 |
| 20 | Sustained-release oral fampridine in multiple sclerosis:a randomised,double-blind,controlled trial显示文摘 | Goodman AD Brown TR Krupp LB | | 0，，9665： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员